Laman UtamaEXEL • NASDAQ
add
Exelixis Inc
$39.15
Selepas Waktu Dagangan:(0.38%)+0.15
$39.30
Tutup: 12 Sep, 8:00:00 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$39.07
Julat hari
$38.59 - $39.27
Julat tahun
$25.17 - $49.40
Permodalan pasaran
10.54B USD
Bilangan Purata
2.71J
Nisbah P/E
18.78
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 568.26J | -10.82% |
Perbelanjaan pengendalian | 335.22J | -2.32% |
Pendapatan bersih | 184.85J | -18.25% |
Margin untung bersih | 32.53 | -8.34% |
Pendapatan bagi setiap syer | 0.75 | -10.71% |
EBITDA | 220.92J | -22.12% |
Kadar cukai berkesan | 19.78% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 791.10J | -21.05% |
Jumlah aset | 2.68B | -3.43% |
Jumlah liabiliti | 644.54J | -1.35% |
Jumlah ekuiti | 2.03B | — |
Syer tertunggak | 269.20J | — |
Harga kepada buku | 5.19 | — |
Pulangan pada aset | 19.36% | — |
Pulangan pada modal | 23.57% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 184.85J | -18.25% |
Tunai daripada operasi | 48.99J | -59.02% |
Tunai daripada pelaburan | 248.03J | 203.32% |
Tunai daripada pembiayaan | -316.34J | -20.55% |
Perubahan bersih dalam tunai | -19.32J | 68.38% |
Aliran tunai bebas | 85.84J | 1,125.90% |
Perihal
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
Diasaskan
15 Nov 1994
Ibu pejabat
Tapak web
Pekerja
1,147
